期刊文献+

复方磺胺甲恶唑联合常规雾化治疗支气管结核的临床疗效观察 被引量:10

Clinical efficacy observation of compound sulfamethoxazole combined with conventional atomization in treatment of bronchial tuberculosis
下载PDF
导出
摘要 目的探讨和分析复方磺胺甲恶唑联合常规雾化治疗支气管结核临床疗效。方法选取2012年1月~2013年10月在湖北民族学院附属民大医院接受治疗的支气管结核患者190例为研究对象,随机分成2组(n=95),对照组行常规雾化治疗,观察组在行雾化治疗的基础上,同时给予复方磺胺甲恶唑治疗,观察和对比2组患者临床治疗效果及不良反应发发生情况。结果持续治疗4~6个月后,观察组治疗显效率为70.5%、总有效率为89.5%,对照组显效率和总有效率分别为48.4%和76.8%,2组显效率和总有效率对比差异显著,均有统计学差异(P<0.05);在细菌转阴时间指标上,观察组和对照组转阴时间分别为(2.6±0.9)个月和(4.2±1.1)个月,2组对比,差异显著有统计学意义(P<0.05);观察组和对照组不良反应发生率分别为7.4%和11.6%,对比差异不显著。结论应用复方磺胺甲恶唑联合常规雾化治疗支气管结核,疗效快,效果显著,细菌转阴时间短,不良反应低,安全性可靠。 Objective To explore clinical efficacy of compound sulfamethoxazole combined with conventional atomization in treatment of bronchial tuberculosis.Methods 190 cases were selected from January 2012 to October 2013 who diagnosised bronchial tuberculosis treated in minda hospital affiliated of Hubei institute for Nationalities,then the patiens were randomly divided into two groups(n=95 ),the control group underwent conventional spray treatment,the observation group row treatment on the basis of atomization,while giving sulfamethoxazole treatment,observation and comparison of two groups clinical outcomes and adverse reactions. Result After continuous treatment for 4~6 months in the observation group therapy effective rate of 70.5%,total effective rate was 89.5%in the control group significant efficiency and total efficiency of 48.4%and 76.8%,respectively,two groups of significant efficiency and total efficiency,there were significant differences(P<0.05 );bacterial turn negative time indicator on the observation group and the control group were respectively(2.6 ±0.9)months and(4.2 ±1.1)months,there was significant difference(P<0.05);adverse reactions in observation group and control group was 7.4% and 11.6%,respectively,which compared no significant difference.Conclusion Application of compound sulfamethoxazole combined with conventional atomization in treatment of bronchial tuberculosis,has quickly and significantly effect,and bacterial clearance time is short,with low adverse reactions,safety and reliable.
出处 《中国生化药物杂志》 CAS 北大核心 2014年第4期154-156,160,共3页 Chinese Journal of Biochemical Pharmaceutics
关键词 支气管结核 常规雾化治疗 复方磺胺甲恶唑 联合治疗 临床疗效 bronchial tuberculosis conventional spray treatment compound sulfamethoxazole combination therapy clinical efficacy
  • 相关文献

参考文献7

二级参考文献10

共引文献149

同被引文献75

  • 1严莉.雾化吸入辅助治疗支气管结核60例[J].浙江中西医结合杂志,2005,15(9):576-577. 被引量:1
  • 2宋春泽,周成合,袁勇.磺胺类碳酸酐酶抑制剂研究进展[J].中国新药杂志,2007,16(18):1438-1444. 被引量:20
  • 3王岩.雾化吸入治疗支气管结核疗效分析.中外健康文摘,2012,(34):106-107.
  • 4World Health Organ{zation. Global tuberculosis report 2012[R]. Geneva : WHO, 2012.
  • 5Zhao Y,Xu S,Wang L,et al. National survey of drug resistant tu berculosis in China[J]. N Engl j Med,g012,366(23) :2161 2170.
  • 6Nguyen I.. Targeting antibiotic resistance mechanisms in Myco- bacterium tuberculosis: recharging the old magic bullets[J]. Ex pert Rev Anti Infect Ther,2012,10(9):963-965.
  • 7Forgacs P,Wengenack NL, ]{all L,et al. Tuberculosis and trime thoprim-sulfamethoxazole [J ]. Antimicrob Agents Chemother, 2009,53(1]) :4789 4793.
  • 8Ong WA, Leslie DE. Mycobacterium tuberculosis and sulfamethoxazole susceptibility[J]. J Antimicrob Chemother, 2010,54 (6) : 2748 2749.
  • 9Vilchze C,Jacobs WR. The combination of sulfamethoxazole, tri methoprim,and isoniazid or rifampin is bactericidal and prevents the emergence of drug resistance in Mycobacterium tuberculosis [J]. Antimierob Agents Chemother,2012,56(10) :5142 5148.
  • 10Alsaad D, Van Altena R, Pranger AD, et al. Evaluation of co tri moxazole in treatment of muhidrug resistant tuberculosis[J]. Eu ro Res[ir J,2012,42(8) :829-837.

引证文献10

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部